Sai Life Sciences Limited has informed the Exchange about Schedule of Earnings Conference call for discussing Un-audited Financial Results of the Company for the quarter ended 30 September 2025.
October 24, 2025
To BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code - 544306
To National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex Bandra East, Mumbai – 400051 Scrip Symbol – SAILIFE
Sub: Intimation of schedule of Analyst / Institutional Investor Meeting.
Dear Sir/ Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company is hosting the Earnings Conference call on Friday, 7th November 2025, at 04:00 PM (IST) for discussing Un-audited Financial Results of the Company for the quarter ended 30 September, 2025.
Complete details of the earnings conference call are attached herewith for your reference.
We request you to take note of the same and oblige.
Thanking You,
For Sai Life Sciences Limited
Runa Karan Company Secretary & Compliance Officer Membership No.: A13721
Encl.: As Above
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office
Registered office
# L4-01 & 02, SLN Terminus, Survey #133, Gachibowli Miyapur Road, Gachibowli, Hyderabad – 500032, Telangana, India.
Plot No. DS-7, IKP Knowledge Park, Turkapally (V), Shameerpet Mandal, Medchal-Malkajgiri (Dist), Hyderabad -500078, Telangana, India.
Contact us T: +91 40 6815 6000, F: +91 40 6815 6199 E: info@sailife.com W: www.sailife.com
Sai Life Sciences Q2FY26 Results Conference Call At 4.00 pm IST on November 07, 2025 (Friday)
We are pleased to invite you to Sai Life Sciences Q2FY26 results conference call with the senior management. The conference call will be held on Friday, November 07, 2025, at 4:00 PM (IST). The call will be initiated with a brief
management discussion on the earnings performance followed by an interactive Question & Answer session
The details of the earnings call are:
Date: November 07, 2025 | Time Slot (IST): 4:00 PM – 5:00 PM
Dial-in Number: +91 22 6280 1107, +91 22 7115 8008
Other Dial in Numbers:
International Toll Free: USA: 18667462133 | UK: 08081011573 | Singapore: 8001012045 |
Hong Kong: 800964448
Pre-Registration Facility for the call and dial in directly without waiting for the operator: Click Here
Or Copy this URL in your browser:
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6058474&linkSecurityString=2e621fba34
Management Representation from Sai Life Sciences Limited Mr. Krishna Kanumuri, Managing Director & Chief Executive Officer
Mr. Siva Chittor, Director and Chief Financial Officer
About Sai Life Sciences Limited
Sai Life Sciences is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) that partners
with innovator pharmaceutical and biotech companies to accelerate the discovery, development, and commercialization of new
medicines. Headquartered in Hyderabad, India, with a strong global presence, the company offers integrated solutions spanning
medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms. Sai Life
Sciences is committed to delivering high-quality, cost-effective, and scalable solutions while upholding the highest standards of
safety, compliance, and integrity. With a focus on innovation and operational excellence, the company continues to strengthen its
capabilities to support emerging therapeutic modalities and meet the evolving needs of the life sciences industry.
For more information, please visit www.sailife.com
For further information please contact: Investorrelation@sailife.com